135 related articles for article (PubMed ID: 15570919)
21. [Clinicopathological characteristics of gastric cancer in elderly patients].
Boku N; Okamoto R; Kandabashi K; Sasaki E; Omuro Y; Maeda Y; Sasaki T
Gan To Kagaku Ryoho; 2006 Aug; 33(8):1099-103. PubMed ID: 16912528
[TBL] [Abstract][Full Text] [Related]
22. Weekly infusional high-dose fluorouracil (HD-FU), HD-FU plus folinic acid (HD-FU/FA), or HD-FU/FA plus biweekly cisplatin in advanced gastric cancer: randomized phase II trial 40953 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group and the Arbeitsgemeinschaft Internistische Onkologie.
Lutz MP; Wilke H; Wagener DJ; Vanhoefer U; Jeziorski K; Hegewisch-Becker S; Balleisen L; Joossens E; Jansen RL; Debois M; Bethe U; Praet M; Wils J; Van Cutsem E; ;
J Clin Oncol; 2007 Jun; 25(18):2580-5. PubMed ID: 17577037
[TBL] [Abstract][Full Text] [Related]
23. Phase I/II study of oxaliplatin with weekly bolus fluorouracil and high-dose leucovorin (ROX) as first-line therapy for patients with colorectal cancer.
Yamada Y; Ohtsu A; Boku N; Miyata Y; Shimada Y; Doi T; Muro K; Muto M; Hamaguchi T; Mera K; Yano T; Tanigawara Y; Shirao K
Jpn J Clin Oncol; 2006 Apr; 36(4):218-23. PubMed ID: 16684860
[TBL] [Abstract][Full Text] [Related]
24. Preoperative chemoradiotherapy for rectal cancer: randomized trial comparing oral uracil and tegafur and oral leucovorin vs. intravenous 5-fluorouracil and leucovorin.
de la Torre A; García-Berrocal MI; Arias F; Mariño A; Valcárcel F; Magallón R; Regueiro CA; Romero J; Zapata I; de la Fuente C; Fernández-Lizarbe E; Vergara G; Belinchón B; Veiras M; Molerón R; Millán I
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):102-10. PubMed ID: 17869446
[TBL] [Abstract][Full Text] [Related]
25. [Borrmann 4 gastric cancer treated with l-LV and 5-FU combination--a case report].
Kato T; Saito Y; Niwa M; Maruyama Y; Ishizuka K; Hasegawa T; Nashimoto A; Ogoshi K
Gan To Kagaku Ryoho; 1992 Mar; 19(3):379-82. PubMed ID: 1543365
[TBL] [Abstract][Full Text] [Related]
26. Biweekly oxaliplatin in combination with continuous infusional 5-fluorouracil and leucovorin (modified FOLFOX-4 regimen) as first-line chemotherapy for elderly patients with advanced gastric cancer.
Liu ZF; Guo QS; Zhang XQ; Yang XG; Guan F; Fu Z; Wang MY
Am J Clin Oncol; 2008 Jun; 31(3):259-63. PubMed ID: 18525305
[TBL] [Abstract][Full Text] [Related]
27. Phase II study of the paclitaxel, cisplatin, 5-fluorouracil and leucovorin (TPFL) regimen in the treatment of advanced or metastatic gastric cancer.
Jung JY; Kwon JH; Kim JH; Song HH; Kim I; Lee KS; Kim HJ; Zang DY; Ahn JS; Lee JA; Park YI
Oncol Rep; 2009 Feb; 21(2):523-9. PubMed ID: 19148531
[TBL] [Abstract][Full Text] [Related]
28. [New combination therapies for gastrointestinal cancer].
Sasaki T; Maeda Y; Kobayashi T; Okamoto R; Omuro Y; Takeda N
Gan To Kagaku Ryoho; 2000 Mar; 27(3):348-55. PubMed ID: 10740627
[TBL] [Abstract][Full Text] [Related]
29. [Significance of neoadjuvant chemotherapy for gastric cancer].
Fujii M; Kochi M; Mochizuki F
Gan To Kagaku Ryoho; 2000 Nov; 27(13):2028-32. PubMed ID: 11103233
[TBL] [Abstract][Full Text] [Related]
30. Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer.
Poplin EA; Benedetti JK; Estes NC; Haller DG; Mayer RJ; Goldberg RM; Weiss GR; Rivkin SE; Macdonald JS
J Clin Oncol; 2005 Mar; 23(9):1819-25. PubMed ID: 15774775
[TBL] [Abstract][Full Text] [Related]
31. Thymidylate synthase and dihydropyrimidine dehydrogenase are related to histological effects of 5-fluorouracil and cisplatin neoadjuvant chemotherapy for primary gastric cancer patients.
Fukuda H; Takiguchi N; Koda K; Oda K; Seike K; Miyazaki M
Cancer Invest; 2006; 24(3):235-41. PubMed ID: 16809149
[TBL] [Abstract][Full Text] [Related]
32. First-line chemotherapy with low-dose leucovorin plus 5-fluorouracil (LV/5-FU) for elderly patients with metastatic colorectal cancer.
Yoshimatsu K; Yokomizo H; Fujimoto T; Umehara A; Otani T; Matsumoto A; Osawa G; Shiozawa S; Katsube T; Naritaka Y; Ogawa K
Anticancer Res; 2007; 27(3B):1641-4. PubMed ID: 17595789
[TBL] [Abstract][Full Text] [Related]
33. Significance of biological markers for predicting prognosis and selecting chemotherapy regimens of advanced gastric cancer patients between continuous infusion of 5-FU and a combination of 5-FU and cisplatin.
Boku N; Ohtsu A; Yoshida S; Shirao K; Shimada Y; Hyodo I; Saito H; Miyata Y;
Jpn J Clin Oncol; 2007 Apr; 37(4):275-81. PubMed ID: 17522103
[TBL] [Abstract][Full Text] [Related]
34. [A new systemic combination chemotherapy to be provided at home for patients with unresectable recurrent colorectal cancer].
Takahashi K; Mori T; Yamaguchi T; Matsumoto H; Miyamoto H; Arai K; Iwasaki Y; Katayanagi S
Gan To Kagaku Ryoho; 2003 Dec; 30(1 Suppl):153-6. PubMed ID: 15311790
[TBL] [Abstract][Full Text] [Related]
35. Biweekly oxaliplatin plus 1-day infusional fluorouracil/leucovorin followed by metronomic chemotherapy with tegafur/uracil in pretreated metastatic colorectal cancer.
Lin PC; Chen WS; Chao TC; Yang SH; Tiu CM; Liu JH
Cancer Chemother Pharmacol; 2007 Aug; 60(3):351-6. PubMed ID: 17111120
[TBL] [Abstract][Full Text] [Related]
36. Randomised study of tegafur and oral leucovorin versus intravenous 5-fluorouracil and leucovorin in patients with advanced colorectal cancer.
Nogué M; Salud A; Batiste-Alentorn E; Saigí E; Losa F; Cirera L; Méndez M; Campos JM; Galan A; Escudero P; Arcusa A; Manzano H; de Mendizábal EV; de Olaguer JP; Boleda M; Guasch I; Vicente P
Eur J Cancer; 2005 Oct; 41(15):2241-9. PubMed ID: 16214045
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of gastric cancer].
Lordick F; Ridwelski K; Al-Batran SE; Trarbach T; Schlag PM; Piso P
Onkologie; 2008; 31 Suppl 5():32-9. PubMed ID: 19033703
[TBL] [Abstract][Full Text] [Related]
38. [Treatment strategy for primary gastric cancer with peritoneal dissemination].
Yoshikawa T; Tsuburaya A; Kobayashi O
Gan To Kagaku Ryoho; 2005 Oct; 32(10):1398-403. PubMed ID: 16227737
[TBL] [Abstract][Full Text] [Related]
39. [IFL].
Yamazaki K; Yoshino T; Boku N
Gan To Kagaku Ryoho; 2006 Jul; 33(7):907-10. PubMed ID: 16835478
[TBL] [Abstract][Full Text] [Related]
40. [Effect of combination chemotherapy with multiple drugs (FLMP therapy) based on the circadian rhythms of the human body in advanced recurrent gastric cancer].
Yokomori T; Iesato H; Kamoshita N; Nagaoka H; Okabe T; Kato Y
Gan To Kagaku Ryoho; 1999 Nov; 26(13):2043-8. PubMed ID: 10584569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
